Hnub tim 1, Lub Ob Hlis, Shanghai Chuangkun Biotechnology Co., Ltd. tau txais daim ntawv pov thawj thib ob ntawm Thaib Teb FDA rau cov khoom kuaj TB/NTM-DNA, tau nqis los ntawm 15 hom HPV kuaj PCR cov khoom siv ib hlis dhau los.uas tshaj tawm tias Chuangkun Biotech cov khoom tau tso cai los ntawm Thaib teb FDA, txhim kho cov khoom tsim tus kheej, thiab tseem muab kev txhawb zog rau Chuangkun Biotech kom nthuav dav thoob ntiaj teb kev lag luam.
Kev kwv yees thoob ntiaj teb tag nrho ntawm 10.6 lab tus tib neeg poob mob TB luam tawm los ntawm WHO hauv 2021.Qhov nce ntxiv los ntawm 4.5% ntau dua li xyoo 2020.Tam sim no 1.6 lab tus tib neeg tuag los ntawm tuberculosis xyoo tas los (xws li 6.7% yog cov neeg nyob nrog HIV) .Raws li thaj chaw, feem ntau tus mob TB hauv xyoo 2021 yog nyob rau hauv WHO thaj tsam ntawm South-East Asia (45%), Africa (23%) thiab Western Pacific (18%), nrog rau feem me me nyob rau sab hnub tuaj Mediterranean (8.1%), Tebchaws Asmeskas. (2.9%) thiab Europe (2.2%).Xav txog qhov COVID-19 kis thoob qhov txhia chaw, kev tiv thaiv tuberculosis thiab kev tswj tau hnyav dua thiab hnyav dua rau Txoj Haujlwm Kev Txiav Txim Tuberculosis rau WHO.
TB/NTM-DNA kuaj cov khoom siv rau CHUANGKUN Biotech yog tsim los ntawm cov txheej txheem lyophilization Cov txheej txheem yuav daws cov teeb meem kev thauj mus los ntev rau cov khoom siv kuaj PCR ib txwm muaj, kuj coj tau qhov tseeb zoo thiab cov txiaj ntsig siab tshaj qhov kev cog lus rau kev siv.
Shanghai Chuangkun Biotechnology Co., Ltd. tau txais daim ntawv pov thawj thib ob ntawm Thaib Teb FDA rau TB / NTM-DNA kuaj cov khoom, qhia kev lees paub los ntawm Thaib teb FDA.Chuangkun Biotech yuav parctise nyob rau hauv lub regional tuberculosis tiv thaiv thiab tswj kom muaj zog.
Post lub sij hawm: Feb-02-2023